1NATHAN H, SEGEV D L, MAYO S C,et al. National tre- nds in surgical procedures for hepatocellular carcinoma: 1998-2008 [ J ]. Cancer,2012,118 ( 7 ) : 1838-1844.
6FABER M S, JETYER A, FUHR U. Assessment of CYP1A2 Activity in clinical practice : why, how, and when? [ J ]. Basic Clin Pharmacol Toxicol, 2005,97 ( 3 ) : 125 - 134.
7JIANG Z, DRAGIN N, JORGE-NEBERT L F, et al. Search for an association between the human CYP1A2 genotype and CYP1 A2 metabolic phenotype [ J ]. Pharmacogenet Genomics ,2006,16( 5 ) :359-367.
8AKLILLU E, CARRILLOJ A, MAKONNEN E, et al. Genetic polymorphism of CYP1A2 in ethiopians affecting induction and expression:characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1 [ J ]. Mol Pharmaco1,2003,64( 3 ) :659-669.
9GHOTBI R, CHRISTENSEN M, ROH H K, et al. Compar- isons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans [ J]. Eur J Clin Pharmacol, 2007,63 ( 6 ) : 537 - 546.
10DJORDJEVIC N, GHOTBI R,JANKOVIC S, et al. Induction of CYP1 A2 by heavy coffee consumption is associated with the CYP1A2 -163C > A polymorphism [ J ]. Eur J Chn Pharmacol, 2010,66 ( 7 ) : 697 -703.
5Makuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol, 1993,9:298-304.
6Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modem era with special reference to remnant liver volume. J Am Coll Surg, 1999,188 : 304 -309.
7Hashimoto M, Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res ,20130 ,92 :222-227.
8Ozawa K. Hepatic function and liver resection. J Gastroenterol Hepatal, 1990,5:296-309.
9Okamoto E, Kyo A, Yamanaka N, et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurement in patients with impaired hepatic failure. Surgery, 1984,95:585-592.
10Makuuchi M ,Hashikura Y ,Kawasaki S,et al. Personal experience of right anterior segmentectomy for hepatic malignancies. Surgery, 1993,114:52-58.
